Intrinsic Value of S&P & Nasdaq Contact Us

Stryker Corporation SYK NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
74/100
5/7 Pass
SharesGrow Intrinsic Value
$411.27
+18.9%
Analyst Price Target
$428.67
+23.9%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Stryker Corporation (SYK) has shown strong revenue growth over the past 3 years, expanding from $18.4B to $25.1B (average +10.8%/yr). Net income reached $3.2B, reflecting solid earnings growth at +12.4%/yr on average. The net profit margin is 12.9%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 64% (high), with a +1.2pp trend over the period. With a $132B market cap and MOAT composite score of 86/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (80/100, Pass) — proving strong growth momentum
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 41-year history, the company was profitable in 41 of 41 years — a perfect long-term track record
  • INCOME (55/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (86/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 74/100 with 5/7 criteria passed.

74/100
SG Score
View full scorecard →
VALUE
32/100
Price-to-Earnings & upside
→ IV page
FUTURE
79/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $8.40
Proven by this page
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
MOAT
86/100
Score: 86/100
GM 64% (+1.2pp)
Proven by this page
GROWTH
80/100
Rev +10.8%/yr
NI +12.4%/yr
Proven by this page
~
INCOME
55/100
Margin 12.9%
$25.1B
Proven by this page
Stryker Corporation Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $25.12B$25.12B$22.6B$20.5B$18.45B
Gross Profit $16.02B$16.07B$14.44B$13.1B$11.58B
Gross Margin 63.8%64%63.9%63.9%62.8%
Operating Income $5.29B$4.89B$3.69B$3.89B$2.84B
Net Income $3.25B$3.25B$2.99B$3.17B$2.36B
Net Margin 12.9%12.9%13.2%15.4%12.8%
EPS (Diluted) $8.40$8.40$7.76$8.25$6.17
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message